Skip to main content
  1. Market Insights
  2. Health
  3. OTC Pharmaceuticals

Other OTC Pharmaceuticals - Pakistan

Pakistan
  • In Pakistan, the revenue generated in the Other OTC Pharmaceuticals market in 2024 amounts to US$27.33m.
  • It is projected that this market will experience an annual growth rate of 1.93% (CAGR 2024-2029).
  • When compared globally, the United States leads in terms of revenue generation, reaching US$7.17bn in 2024.
  • In relation to the total population figures, per person revenues of US$0.11 are generated in Pakistan in 2024.
  • The Other OTC Pharmaceuticals market holds significant potential in the country.
  • The demand for Other OTC Pharmaceuticals in Pakistan is increasing due to the rising awareness of self-medication and the availability of a wide range of affordable products.

Definition:
The Other OTC Pharmaceuticals market encompasses a range of non-prescription pharmaceuticals and medical products that are available for purchase without a prescription. This category includes various products that are not explicitly covered in other submarkets, such as oral treatments, ear drops, female contraception, smoking cessation aids, hair growth products, and more. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Additional information:
The market for Other OTC Pharmaceuticals comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

In-Scope

  • Oral treatments
  • Ear Drop
  • Female Contraception
  • Smoking Cessation Aids
  • Hair Growth Product

Out-Of-Scope

  • Prescription Medications
  • Medical Equipment and Devices
OTC & Pharmaceuticals in Germany 2023 - Cover

Consumer Insights data table

OTC & Pharmaceuticals in Germany 2023

Study Details

    Revenue

    Notes: Data shown is using current exchange rates and reflects market impacts of the Russia-Ukraine war.

    Most recent update: Mar 2024

    Source: Statista Market Insights

    Most recent update: Mar 2024

    Source: Statista Market Insights

    Analyst Opinion

    The Other OTC Pharmaceuticals market in Pakistan has been witnessing significant growth in recent years.

    Customer preferences:
    Customers in Pakistan have shown a growing preference for over-the-counter (OTC) pharmaceutical products. This can be attributed to several factors. Firstly, OTC medications are easily accessible and do not require a prescription, making them convenient for consumers. Additionally, the cost of OTC drugs is often lower compared to prescription medications, making them more affordable for a larger segment of the population. Furthermore, the increasing awareness about self-care and the importance of preventive healthcare has also contributed to the demand for OTC pharmaceuticals in Pakistan.

    Trends in the market:
    One of the key trends in the Other OTC Pharmaceuticals market in Pakistan is the increasing demand for vitamins and dietary supplements. This can be attributed to the growing health consciousness among consumers, who are seeking to improve their overall well-being. Vitamins and dietary supplements are seen as a convenient way to fill any nutritional gaps in the diet and support various aspects of health, such as immunity, bone health, and cognitive function.Another trend in the market is the rising popularity of herbal and traditional remedies. Pakistan has a rich tradition of herbal medicine, and many consumers are turning to these remedies for various health issues. The demand for herbal and traditional OTC products is driven by the perception that they are natural and have fewer side effects compared to synthetic drugs.

    Local special circumstances:
    Pakistan has a large population, which presents a significant market opportunity for OTC pharmaceutical companies. The country's healthcare infrastructure is still developing, and access to healthcare services, including prescription medications, can be limited in certain areas. This creates a favorable environment for the growth of the OTC pharmaceutical market, as consumers rely on these products for self-care and minor ailments.Furthermore, the presence of a strong retail sector in Pakistan contributes to the growth of the OTC pharmaceutical market. Pharmacies and drugstores are easily accessible to consumers, and they play a crucial role in the distribution of OTC products. The availability of a wide range of OTC medications in these retail outlets further fuels the demand for such products.

    Underlying macroeconomic factors:
    The growing middle class in Pakistan is a key driver of the OTC pharmaceutical market. As disposable incomes rise, consumers are willing to spend more on healthcare and wellness products. This has led to an increased demand for OTC medications, as consumers seek to manage their health and well-being.Additionally, the government's focus on healthcare and initiatives to improve access to healthcare services have also contributed to the growth of the OTC pharmaceutical market. The government has taken steps to regulate and promote the OTC sector, which has created a favorable business environment for companies operating in this space.In conclusion, the Other OTC Pharmaceuticals market in Pakistan is witnessing significant growth due to customer preferences for accessible and affordable healthcare options, including vitamins, dietary supplements, and herbal remedies. The country's large population, developing healthcare infrastructure, strong retail sector, and growing middle class are all contributing to the expansion of the market. Additionally, government initiatives and regulations are further supporting the growth of the OTC pharmaceutical sector in Pakistan.

    Global Comparison

    Most recent update: Mar 2024

    Source: Statista Market Insights

    Methodology

    Data coverage:

    Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

    Modeling approach / Market size:

    Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

    Forecasts:

    In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

    Additional notes:

    Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

    Health

    Access more Market Insights on Health topics with our featured report

    OTC & Pharmaceuticals in Germany 2023 - BackgroundOTC & Pharmaceuticals in Germany 2023 - Cover

    Key Market Indicators

    Notes: Based on data from IMF, World Bank, UN and Eurostat

    Most recent update: Sep 2024

    Source: Statista Market Insights

    Contact

    Get in touch with us. We are happy to help.